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Procedural sedation and analgesia (PSA) is defined as a technique of 
administering sedatives or dissociative agents with or without analgesics to 
induce a state that allows the patient to tolerate unpleasant procedures while 
maintaining cardiorespiratory function.
(1)
 It was previously referred to as 
conscious sedation. 
This technique is used in the emergency department for the performance of 
painful or uncomfortable procedures. It has been used for setting fractures, 
draining abscesses, reducing dislocations, performing endoscopy, imaging 
procedures, dilatation and curettage for evacuation of retained products of 
conception (D & C), cardioversion
(2)
 and during dental procedures. 
In recent years PSA has gained popularity for a number of reasons, amongst 
which are improved patient-outcomes & cost-containment benefits, 
development of newer, better and safer drugs and techniques and better 
practitioner skills
(3)
. PSA is well perceived by patients 
(4). Patient demand for 
this cost-effective and time-saving technique that offers the patient a reduced 
duration of hospital stay is increasing. 
 
Rationale 
The author’s research was prompted by her experience that pain relief is often 
not a priority for the medical and nursing staff, despite the fact that pain is 
often the reason why the patient attends the health facility. In fact pain is the 
most common presenting symptom in the Emergency Department (ED). More 
than 60 percent of ED patients have pain as their main symptom or a major 
part of their symptoms 
(5)
.This seems to be a global phenomenon.  
While the patient’s main agenda is to obtain pain relief, the physician is 
focused on diagnosis and treatment of the underlying disease process. This 
leads to discordance between the expectations of the patient and the focus of 

















A review of multiple publications, published in “Pain Management” has 
identified a number of causes for poor management of painful conditions in 
the ED: failure of ED staff to acknowledge pain, failure to assess initial pain, 
failure to have pain management guidelines in ED, failure to document pain 
and to assess treatment adequacy, and failure to meet patient’s expectations. 
The barriers that preclude emergency physicians from proper pain 
management include ethnic and racial bias, gender bias, age bias, inadequate 
knowledge and formal training in acute pain management and opiophobia of 
hospital staff
(6)
 .  
The author’s interest in procedural pain and pain relief in particular was 
sparked by witnessing painful procedures being performed in Emergency 
Departments on children and adults without administration of any analgesia 
and/ or sedation support. 
Being able to safely relief pain that comes with such procedures, and provide 
a degree of immobility, not only leads to greater patient satisfaction and less 
post-traumatic stress, but also to easier working conditions for the ED doctor 




A pubmed search on English language articles between 1990 and April 2010 
was performed using combinations of the key words “conscious sedation”, 
“moderate sedation”, “deep sedation”, “procedural sedation”, “conscious 
sedation versus general anaesthesia”, "procedural sedation versus general 
anaesthesia”, “moderate sedation versus general anaesthesia”, “deep sedation 
versus general anaesthesia”, “cost”, “cost analysis”, “cost comparison”, 
“economy”, “incomplete abortion”, ”missed abortion”, “miscarriage” 
“Ketamine”, “Midazolam”, “Opioids”, “Propofol”, “Ketafol”, “day case 
surgery”, “efficacy”, “safety”, “adverse events”, “side-effects”, 
“complication”, “morbidity”, “mortality”, “analgesia”, “sedation”, 
“emergency department”,  “emergency department analgesia”, “interventional 

















missed abortion”, “anaesthetic management of missed abortion”, “South 
Africa” and “family physician”.  Terms were then exploded as appropriate.  
 
Lack of analgesia in the ER setting 
An American study found that amongst 1727 procedures performed in the 
emergency department of a paediatric department with 20,000 patient visits 
per year, few to no patients undergoing venipuncture, intravenous catheter 
placement, fingersticks, intramuscular or subcutaneous injections, urethral 
catheterization, or nasogastric tube placement received pain management. 
Nearly all patients undergoing fracture reductions received procedural 
sedation with ketamine, and most of the lacerations repaired with sutures and 
nail avulsions received injected local anaesthetic. Pain management of abscess 
incision and drainage and lumbar punctures was more variable. For lumbar 




All too often physical restraint of children and adults is still seen and 
considered an appropriate form of immobilization for painful or anxiety-
provoking procedures. 
 
Effects of oligoanalgesia 
Studies have shown that as a result of poor (procedural) analgesia, children 
become more anxious for further procedures and sensitized to pain in a way 
that decreases their pain threshold in later life
(9)
. Stress associated with painful 
procedures can influence physiological, social and cognitive outcome 
(10)
. 
Studies have concluded that procedural pain and distress, can endure in 
memory, resulting, for example, in disturbances of feeding, sleeping, and the 
stability of the state of arousal. It is known today that early experiences of 
pain may produce permanent structural and functional reorganization of 

















experiences of pain 
(11)
  and have emotional and psychological implications 
for children and families 
(12)
. 
To put it simply, it is inhumane to allow any individual to suffer pain 
unnecessarily, when most emergency departments (ED) have the equipment 
and drugs to provide safe and appropriate analgesia to their patients.  
 
Adverse effects of PSA 
The use of PSA does carry some inherent risks. Nausea and vomiting are not 
uncommon with sedation
 
agents such as Nitrous Oxide 
(13)
 or Ketamine. The 
most serious adverse outcome of any form of paediatric (and adult) sedation
 
is 




Medical statistics differ with regards to numbers of adverse effects (AE) with 
conscious sedation, depending on what drugs are used and what is classified 
as an adverse effect.  
 
Citation Design PSA Drugs used Results Other findings 





study of 1244 PSA 
events in 1215children 
and young adults 
between 2 months and 
19.4 years 
IV fentanyl/ midazolam 
in (n=734) 
 









Successful PSA in 1177 of 
1194 PSA events (98%). 
 
207 of 1161 (17.8%) adverse 
events, of which 93% (193 
subjects) had hypoxia (Sats< 
93%), treated with oral 
airways, reversal agents, bag-
mask ventilation, followed 
by vomiting in 6.2% (13 
patients) 





Med 2005 (18) 
 
A retrospective 
comparative analysis of 
2500 ED patients age 19 
days to 32 years. 

















No non-parental sedation 
 
458 adverse events in 426 
patients (17%); of these 201 
(44%) with resp adverse 
event; 
175  (38%) with vomiting 
Midazolam/ fentanyl group 
associated with increased risk 
of resp. events; 
 




















 Pena BM, et 
al. Ann Emerg 
Med.1999 (19) 
Prospective descriptive 
study of 1180 ED 
patients, under 21 years, 
receiving PSA 
Parenteral and non-
parenteral sedation for 
painful procedures and 
imaging 
27 of 1180 (2.3%) patients 
experienced adverse events, 
16 of which had respiratory 
adverse event, the rest 
vomiting. 
Hypoxia defined as Sats< 
90% 
No serious complications. 
Lower number of side effects 
possibly due to inclusion of 
non parenteral sedation and 
less strict definition of 
hypoxia; 






Analysis of 118 
adverse sedation events 




Variety of PSA 
medications 
95 incidences with consensus 
agreement: 51 deaths, 9 
neurol. injury, 21 prolonged 
hospitalization; 14 no harm; 
Adverse outcomes (permanent 
neurol. Injury or death) 
associated with: non-hospital 
based facility, 
inadequate monitoring and 









Analysis of 498 adverse 
sedation events (UK) 
involving iv midazolam; 
IV midazolam 3 deaths; 48 patients 
sustained moderate harm; 
447 patients with no or low 
harm 
Medication errors (dosages) 
due to problematic packaging 
and lack of staff training were 
main contributors to poor 
outcome. 
 Green SM, et 







Patient data Meta 





analysis to determine 
clinical predictors of 
airway and respiratory 
adverse events 
Ketamine sedation Airway and respiratory 
adverse event rate of 3.9% 
Predictors of adverse 
respiratory events: 
 
-Age < 2yrs or >13 yrs;  
 
-High iv dosing of ketamine 
(>2.5mg/kg initially or > 






-Underlying physical illness; 
 
-Oropharyngeal procedures;  
 






Guidelines for PSA 
In order to keep adverse effects of PSA to a minimum, many specialty 
societies and regulatory bodies have published guidelines for procedural 
sedation and analgesia each designed to address their specific priorities. 
Factors like medication errors or other human mistakes can probably never be 
fully avoided. However, most issues associated with adverse outcomes have 
been addressed in all of the well-known guidelines. The issues that are 

















appropriate skills of sedationist as well as facilities and minimum equipment 
requirements.  The most widely circulated guidelines were produced by  
1) The American Society of Anaesthesiologists (23),  
2) The American College of Emergency Physicians (24) and 
3) The American Academy of Paediatrics (25).   
 
While South Africa has its own set of guidelines, they are not regularly 




The practice guidelines for sedation and analgesia by non-anaesthetists 
(22)
 
recommend that “individuals responsible for patients receiving sedation-
analgesia should understand the pharmacology of the agents that are 
administered, as well as the role of pharmacologic antagonists for opioids 
and benzodiazepines. Individuals monitoring patients receiving 
sedation/analgesia should be able to recognize the associated complications. 
At least one individual capable of establishing a patent airway and positive 
pressure ventilation should be present whenever sedation analgesia is 
administered.” 
An ACLS (Advanced Cardiac Life Support) and PALS (Paediatric Advanced 
Life Support) qualification is generally seen as desirable. 
 
Barriers to the use of PSA 
While PSA should not be undertaken lightly and the sedationist should adhere 
to guidelines and be appropriately trained, the solution is not to leave all 
sedation events to the specialist anaesthetist alone. While anaesthetists have 
unique qualifications to provide sedation, their availability is variable 
(27) and 
is limited by commitments to the operating room 
(28)
.   
Level 1 health care facilities in South Africa don’t usually employ specialists 

















determined in the L1/L2/L3 Acute Hospital Packages of care Booklet 
(29)
, 
published by the Department of Health.  
Despite this argument it is the author’s personal experience that anaesthetists 
are often not very supportive of PSA performed by non-anaesthetists. 
A study from Scotland confirms this opinion. A questionnaire was designed to 
gauge opinion of consultant anaesthetists in Scotland on the practice of 
conscious sedation by dentists. Of the 366 questionnaires sent, 235 were 
returned and valid. In general, those questioned felt that the provision of 
sedation in a hospital setting was more appropriate than in general dental 
practice. While a majority (65%) thought that it was unrealistic for 
anaesthetists to provide all sedation for dental treatment, 63% of the 
questioned anaesthetists also disagreed with current dental sedation practice 




Models of PSA administration  
To provide a solution for this dilemma more and more sedation services are 
relying on nursing staff to provide sedation for certain procedures.  
 
Citation Design PSA Drugs used Results Other findings 
Bassett K, et al. Can J 
Ophthalmol. 2007 (31) 
Prospective 
comparatative 
case study of 105 
patients received 
PSA for cataract 








oral or IV 
midazolam, iv 
fentanyl 
Similar efficacy and 
safety in both groups; no 
statistical difference; No 

























 Sury MRJ , et al. The 
Lancet 1999 (32) 
Retrospective 
case analysis of 
1155 sedation 













Success in 97% (chloral 
hydrate group) and 92% 
(temazepam/ droperidol 
group). Seven minor 
incidents, none of which 
required admission 
PSA administered by non-specialists in the ED 
PSA administered in an emergency department setting requires a different set 
of skills due to greater variability of presenting patients and pathologies. 
Drugs and dosages have to be adjusted and titrated to suit individual patients’ 
needs. Also, patients are often not fasted and sometimes intoxicated, so that 
airway and monitoring skills have even greater priority than in the setting of
elective procedures like cataract surgery or sedation for MRIs as described
above. 
ED procedures are often very painful so patients are more likely to require
deep sedation with its associated risk of respiratory depression, loss of airway
and hypoxia. 
While a number of studies have examined the skills of dedicated Emergency
Physicians in terms of procedural sedation and analgesia, there is very little 
literature on the safety of procedural sedation administered by family
physicians. At least in South Africa (and many rural settings around the 
world) the family physician is often responsible for provision of care in the
emergency department of the District Hospitals and Community Health 
Centres.
The author found only one study from a rural hospital in Canada which 
described use of potent pharmacological agents for procedural sedation at the 
hands of the medical officers and family physicians staffing the ED of this 
hospital 
(33)
. Equally, no articles were found regarding the use of procedural

















This research is examining the outcome of PSA administered by Medical 




Cost of PSA versus GA 
Literature on cost analysis was in general scarce. The studies that were done 
incorporated small patient numbers and were difficult to compare because 
they used different costing models.  
One study evaluated 226 patients below 18 years of age who underwent 296 
endoscopic procedures. The group was randomized into an intravenous 
sedation arm and a GA arm. Efficacy, safety, and cost in both arms were 
compared. While efficacy and safety was equally satisfactory in both groups, 
the conscious sedation group was on average charged at $768.52, less than 
half that of the GA group at $ 1965.42 
(34)
. 
While this agrees with intuitive thinking and many articles mentioning cost 
containment as one of the advantages of PSA without necessarily quoting 
studies 
(3)
, an interesting American cost comparison was published in 2001, 
analyzing cost for GA and PSA in 22 children, having dental treatment. In this 
study healthy children between 2 and 5 years received GA for dental 
treatment. The cost for conscious sedation for the same child was then 
estimated, using a costing model that included societal costs, such as 
estimated loss of income for the parent accompanying the child. Costs were 
estimated to be greater in the PSA group since some children would not 
complete treatment under sedation and would have to return for a second 
appointment for dental treatment under GA 
(35)
. 
While this article is interesting the author believes the South African public 
health perspective might differ from the American view, even if societal costs 

















unemployed or are in low income employment so that the impact of societal 
costs will be less than estimated in America.  
Also, D&C in adults differs from dental treatment in children in that 
completion of almost 100% of procedures would be expected. 
No articles were found comparing the cost of dilatation and curettage (D&C) 
under general anaesthesia (GA) to procedural sedation and analgesia (PSA). 
Research questions 
1) What were the outcomes of patients who had PSA at False Bay Hospital 
between March 2007 and August 2009 in terms of efficacy, adverse 
effects and patient satisfaction 
1
 
2) What is the cost of PSA versus GA in patients that have undergone D&C 






False Bay Hospital is situated in Fish Hoek in the southern suburbs of the 
Cape Town Metro Health District. It is a District Hospital with capacity of 75 
inpatient beds. It has two operating theatres, an OPD and a Casualty 
department with an annual headcount of about 14000 patients.  
The Casualty department, at the time the study was conducted, was mainly 
staffed by medical officers, with post-graduation working experience between 
5 and 12 years.  
One medical officer and three nursing staff usually staff each shift with an 
option of calling in additional members of staff should this be required.  
None of the doctors working in the ED had any formal emergency medicine 
or anaesthetic training at the time. All sedation providers had attended the 
ACLS and PALS (or equivalent) courses. 
                                                          
1
 Patient satisfaction questionnaire was not conducted retrospectively because of predicted poor returns. 
2

















Due to lack of trained staff the hospital had no PSA service prior to 
commencement of the study. Procedures in the ED were either conducted 
without PSA or referred to a secondary hospital. 
Dilatation and Curettage of RPOC were only undertaken on selected days 
when a local General Practitioner (GP) with a diploma in anaesthetics (DA) 
was available. Due to other commitments his attendances were irregular and 
not always predictable. On days when the GP was unavailable, patients who 
required a D&C were referred to the secondary hospital. 
The author attended a two year diploma course in conscious sedation at UWC 
and subsequently provided in-house training of interested medical and nursing 
staff. 
Subsequently a PSA service was developed at False Bay Hospital, beginning 
from March 2007. 
All required equipment was available in the ED of the hospital. 
After consultation with theatre and ED staff it was decided to conduct D&Cs 
for RPOC in the hospital’s operating theatre (OT). This was a logistic 
decision, to avoid blockade of the ED. It was also expected that sedation for 
the D&Cs would need to be deeper than for standard emergency procedures, 
since a D&C is a longer procedure with a varying pain stimulus. As such, the 
patient would benefit from better staffing and monitoring facilities of the OT 
compared to the ED. 
Standard guidelines for procedural sedation (20
)
 were followed with selection 
of appropriate drugs and dosages being left to the discretion of the trained 
sedation provider. 
A logbook was kept by the author of all sedations conducted by herself or 


















1) To determine safety, efficacy and patient satisfaction3 of procedural 
sedation and analgesia (PSA) in a South African district hospital staffed 
by non-specialists 
2) To evaluate cost of PSA versus GA in patients who received PSA for 





1. To retrospectively describe PSA as performed for emergency procedures 
in the ED and for D&Cs in the OT. 
2. To report success of sedation and analgesia. 
3. To report adverse events. 
4. To report time to recovery. 




This study is a retrospective, descriptive series of a consecutive sample of ED 
patients receiving PSA. 
 
Methods 
All patients that presented to the ED of False Bay Hospital, a level one 
hospital in the Southern suburbs of the Cape Town Metro health district, 
between March 1 2007 and August 30, 2009, requiring PSA will be 
retrospectively evaluated. 
Sample Size 
                                                          
3
 See above, patient satisfaction questionnaire not conducted. 
4















The sample consisted of 161 patients, of which 133 received PSA in the ED. 
A further 28 patients attended with incomplete abortions and had a dilatation 
and curettage (D&C) for retained products of conception (RPOC) in the OT. 
These 28 patients differed in their make up in that they were treated like 
elective cases, as opposed to the emergency cases treated in the ED. The 
patients suffering from miscarriages were fasted and their procedure was 
performed in the OT instead of ED. 
Patient selection 
Patients that received medications for the purpose of procedural sedation and 
analgesia, either orally, inhalational or intravenously will be included. Female
patients that suffered an abortion and were treated in the OT of the same 
hospital with a D&C under PSA for RPOC will also be included.
Patients who received any drugs used for PSA for endotracheal intubation,
seizure control, and analgesia without associated procedure were not included
in the study.
The treating medical officer in the Casualty department was responsible for
selection of patients that were deemed suitable for PSA at a level 1 facility, as 
well as choice of agents and concentrations used for PSA. 
Patients selected for PSA at False Bay Hospital were generally “healthy”,
meaning ASA (American Society of Anaesthetists classification) 1 or 2, or
stable ASA 3 patients, free of psychiatric disease.
The ASA physical status classification system is a system that assesses a patient’s 
fitness for surgery. It classifies patients from one to six with the following 
meaning: 
1=A normal healthy patient; 2=A patient with mild systemic disease; 3=A patient 
with severe systemic disease that limits function, but is not incapacitating; 4=A 
patient with severe systemic disease that is a constant threat to life; 5=A 
moribund patient who is not expected to survive without the operation; 6=A 

















Fasting status and intoxication with alcohol was evaluated and decision to 
proceed or defer procedure was made on a case to case basis by the 
responsible MO. 
 Patients with a viable pregnancy in need of PSA were referred to a level 2 
hospital. A pre-sedation history and examination was conducted on all 
patients by the medical officer in the ED to determine general health and 
exclude allergies to PSA medications. The examination included evaluation of 
airway. Patients with airway problem or health problems that were found 
unsuitable for PSA in the described setting were referred to a level 2 hospital 
for treatment. Blood pressure, heart rate, temperature and O2 Saturation were 
performed as routine pre sedation assessment and patients were monitored 




PSA medication used, included oral and intravenous (iv) midazolam, iv- 
ketamine, iv- morphine, iv-propofol and inhaled nitrous oxide in individually 
titrated dosages and combinations of above. 
Consent 
Informed co sent was obtained for the purpose of PSA and procedure. In 
similar studies (17, 33), consent was waived for actual data review, and the 
author assumes that the same applies here. All data will be used without 
identifying patient details. 
 
Monitoring of patients 
All findings were recorded in the patients’ record and in the case of the D&C 

















During PSA, patients were monitored either by the sedation provider or, in the 
case of sedation provider and operator being the same person by a trained 
nursing sister. 
Heart rate and oxygen saturation was routinely monitored in all patients. 
Verbal contact was maintained throughout the procedure. All findings were 
recorded in the patient folder. 
During all D&Cs there were at least two doctors present and ECG was 
monitored in addition to HR, blood pressure (BP) and oxygen saturation. 
Patient demographics (sex, age, ASA classification, fasting status, level of 
intoxication), PSA medications used, any adverse events, outcomes, rescue 
manoeuvres and discharge times were recorded for each patient in a 
standardized logbook which will be expanded and used as the data capture 
sheet (appendix 2). 
 
 
Discharge of patients 
Following the procedure, patients were monitored in the short stay ward until 
they were considered ready for discharge by the attending nursing sister and/ or 
Casualty MO. 
Patients were considered ready for discharge, once they were:  
1) alert/oriented to time/place/person, and conversant with clear articulation (age 
appropriate); 
2) patient's cardiovascular and respiratory status were assessed to be stable and 
within presedation levels; 
3) patient was able to move and coordinate all muscle groups to the same extent as 
prior to sedation; 
















Above described discharge criteria correlate with an Aldrete score of 9/10. The 
Aldrete score is a post anaesthetic scoring system evaluating readiness of patient 
for discharge.  
Data collection 
The author, to her knowledge, was involved in the care of all patients receiving 
PSA at False Bay Hospital, either as sedation provider, operator or training staff. 
The logbook was a requirement for the “Conscious sedation course” at UWC that 
the author attended. At the time the study was not planned. 
It is planned to review all ED records of attendances that occurred in the 
stipulated time frame to ensure that no PSA event is missed. A review of patient 
records, anaesthetic sheets as applicable and nursing notes of the patients that 
received PSA in the stipulated time frame is intended. Additionally, review of
records of morbidity and mortality (M&M) meetings and review of complaints
that occurred from March 2007 to now is planned to identify adverse events that 
were not recorded in the patient records or occurred after discharge.
Presentation of results 
Clinical and demographic data will be presented as means (SDs), medians,
ranges, and proportions. Success of sedation and incidence of adverse effects will
be presented as proportions.
Classification of adverse effects 
Adverse events were categorized as follows: 1) apnoea- no respiratory effort 
for >20sec; 2) desaturation-O2 saturation < 93%; 3) airway manoeuvre 
required (bag/valve ventilation) 4) bradycardia- HR<50 beats; 5) inadequate 
sedation+/- cancellation of procedure due to failure of PSA; 6) vomiting/ 
nausea; 7) hallucinations; 
For each PSA regimen used, comparison will be made between those patients 


















Record reviews risk contravening patient confidentiality. However, in this 
situation, the researcher was involved in the care of the patients described, so 
confidentiality will not be broken as far as the record review goes. No 
identifying details will be disclosed so patients will remain anonymous.  
The use of the hospital’s name could result in damaging publicity should part 
of this study be published.  
Consent for review of records and use of the hospital name was obtained from 
the senior medical superintendent of False Bay Hospital, who is also one of 
the research supervisors. 
In similar studies from overseas 
(17,33)
 the Ethics committee ruled that 
individual patient consent for review of patient records was not required and 
the author therefore assumes that the same applies here. 
All patients were consented for the sedation and the procedure. 
The number of patients is moderate and from one District Hospital only. 
However, the author believes that the clinical setting of this hospital is 
comparable to other Level 1 Health Care Facilities in the Western Cape and 
findings can probably be generalized to District Hospitals in the Metro 
District. 
While drug regimens used were not standardized, all patients were treated 





The author was involved in the medical care of all examined patients and in 
data collection. This is a source for bias as she might prefer positive results. 
All original patient records are accessible for perusal. 
Other recorded outcome measures were more objective, like the recording of 
vital times and discharge times which was done mostly by nursing staff, 

















The additional review of M&M records and patient complaints might not 
guarantee a completely unbiased view, but will add different perspectives 
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Objectives of literature review and search strategy 
A literature search to explore availability, efficiency and outcomes of 
procedural sedation and analgesia (PSA) in various clinical settings was 
conducted using “Pubmed” and “Google scholar” in search for English 
language articles between 1990 and April 2010. Combinations of the key 
words “conscious sedation”, “moderate sedation”, “deep sedation”, 
“procedural sedation”, “conscious sedation versus general anaesthesia”, 
"procedural sedation versus general anaesthesia”, “moderate sedation versus 
general anaesthesia”, “deep sedation versus general anaesthesia”, “cost”, “cost 
analysis”, “cost comparison”, “economy”, “incomplete abortion”, ”missed 
abortion”, “miscarriage” “Ketamine”, “Midazolam”, “Opioids”, “Propofol”, 
“Ketafol”, “day case surgery”, “efficacy”, “safety”, “adverse events”, “side-
effects”, “complication”, “morbidity”, “mortality”, “analgesia”, “sedation”, 
“emergency department”,  “emergency department analgesia”, “interventional 
pain management”, “dilatation and curettage”, “surgical management of 
missed abortion”, “anaesthetic management of missed abortion”, “South 
Africa” and “family physician” were used.   
Lack of analgesia in the Emergency Room setting 
The ability to provide safe and effective sedation and analgesia is an 
important skill for physicians involved in emergency care. Patients are prone 
to anxiety in the acute setting and benefit greatly from sedation and analgesia. 
Despite this, it is often underused due to misconceptions and unfamiliarity 
with the drugs or the procedure. 
Table 1: Oligoanalgesia in Emergency Departments 









Review of 198 patient 
charts of patients 
attending ED for painful 
conditions; 56% of 
patients received no 
analgesia while awaiting 
treatment. They waited 
over one (69%) or two 
(42%) hours. One third 
received sub-optimal 

























401 patients in 8 EDs 
with acute bone 
fractures. Only 121 










172 children with 




small numbers; patients 









208 children with burns 
attending ED. Average 










1700 procedures in a 
paediatric ED. No 




puncture. Most I&D of 
abscesses done without 
analgesia; 71% of LPs 
in children under 4 
months were done 
without analgesia 
Large numbers of study 
participants; study 
relevant to research 
topic as procedural 
sedation was examined; 
retrospective study; 
indication of analgesia 
for NGT insertion etc is 
questinable 
 
All too often physical restraint of children and adults is still seen and 
considered an appropriate form of immobilization for painful or anxiety-
provoking procedures. 
Effects of oligoanalgesia 
Studies have shown that as a result of poor (procedural) analgesia, children 
become more anxious for further procedures and sensitized to pain in a way 
that decreases their pain threshold in later life 
(14)
. Stress associated with 
painful procedures can influence physiological, social and cognitive 
outcome
(15)
. Studies have concluded that procedural pain and distress, can 
endure in memory, resulting in disturbances of feeding, sleeping, and the 
stability of the state of arousal. It is known today that early experiences of 
pain may produce permanent structural and functional reorganization of 

















experiences of pain 
(16)
  and have emotional and psychological implications 
for children and families 
(17)
. 
It is inhumane to allow any individual to suffer pain unnecessarily, when most 
emergency departments (ED) have the equipment and drugs to provide safe 
and appropriate analgesia to their patients.  
 
 
Adverse effects of PSA 
While provision of analgesia is important in all patients with painful 
conditions, this applies even more in patients undergoing painful or anxiety-
provoking procedures. 
However, the use of PSA does carry some inherent risks. Nausea and 
vomiting are not uncommon with sedation
 
agents such as Nitrous Oxide 
(17)
 or 
Ketamine. The most serious adverse outcome of any form of paediatric (and 




Medical statistics differ with regards to numbers of adverse effects (AE) with 
conscious sedation, depending on what drugs are used and what is classified 
as an adverse effect (table 2).  
 
Table 2: Adverse events of PSA 
Citation Design PSA Drugs used Results Other findings/ 
Limitations 














between 2 months 














Successful PSA in 1177 
of 1194 PSA events 
(98%). 
 
207 of 1161 (17.8%) 
adverse events, of which 
93%  (193 subjects) had  
hypoxia (Sats< 93%), 
treated with oral airways, 
reversal agents, bag-
mask ventilation, 
followed by vomiting in 
6.2% (13 patients) 
No serious adverse 
effects, No mortality, 





arranged; good study, 
relevant to topic; 



























analysis of 2500 
ED patients age 


























458 adverse events in 
426 patients (17%); of 
these 201 (44%) with 
respiratory adverse 
event; 
175  (38%) with 
vomiting 
Midazolam/ fentanyl 
group associated with 










number of trial 
participants; 
Adults and paediatric 
patients included 
 
 Pena BM, 






of 1180 ED 









27 of 1180 (2.3%) 
patients experienced 
adverse events, 16 of 
which had respiratory 
adverse event , the rest 
vomiting. 
Hypoxia defined as Sats< 
90% 
No serious complications. 
Lower number of side 
effects due to inclusion of 
non parenteral sedation 
and less strict definition 
of hypoxia; 
















Variety of PSA 
medications 
95 incidences with 
consensus agreement: 51 
deaths, 9 neurol. injury, 
21 prolonged 
hospitalization; 14 no 
harm; 
Interesting design; 
Analysis of adverse 
events only; Adverse 
outcomes (permanent 
neurol. Injury or death) 
associated with: non-

































Iv midazolam 3 deaths; 48 patients 
sustained moderate 
harm; 447 patients with 
no or low harm 
Medication errors 
(dosages) due to 
problematic packaging 
and lack of staff training 
were main contributors to 
poor outcome. 
 Green SM, 






Patient data meta 














Airway and respiratory 
adverse event rate of 
3.9% 
Predictors of adverse 
respiratory events: 
-Age < 2yrs or >13 yrs;
-High iv dosing of
ketamine (>2.5mg/kg









-IV vs IM route
Large number of patients 
from 32 ED departments; 
Well designed 
observational study 
However as observational 
study not ideally designed 
to draw conclusions about 
treatment 
PSA Guidelines 
In order to keep adverse effects of PSA to a minimum, many specialty 
societies and regulatory bodies have published guidelines for procedural 
sedation and analgesia, each designed to address their specific priorities. 
Factors like medication errors or other human mistakes can probably never be 
fully avoided. However, most issues associated with adverse outcomes have 
been addressed in all of the well-known guidelines. All known guidelines 
emphasize importance of presedation patient assessment, monitoring of the 















equipment requirements. The most widely circulated guidelines were 
produced by:  
4) The American Society of Anaesthesiologists 
(27)
,
5) The American College of Emergency Physicians 
(28)
 and
6) The American Academy of Paediatrics 
(29)
.
While South Africa has its own set of guidelines, they are not regularly 




The practice guidelines for sedation and analgesia by non-anaesthetists
(27)
recommend that “individuals responsible for patients receiving sedation-
analgesia should understand the pharmacology of the agents that are 
administered, as well as the role of pharmacologic antagonists for opioids
and benzodiazepines. Individuals monitoring patients receiving 
sedation/analgesia should be able to recognize the associated complications. 
At least one individual capable of establishing a patent airway and positive
pressure ventilation should be present whenever sedation analgesia is 
administered.”
While not (yet) mandatory for the medical or dental practitioner administering 
procedural sedation, an ACLS and PALS qualification is seen as desirable. 
This point was made on a number of occasions during the lectures that formed 
part of the conscious sedation diploma course at the University of Western
Cape. ACLS or PALS certificate enables the practitioner to rescue patients 




Barriers to the use of PSA 
While PSA should not be undertaken lightly and the sedationist should adhere 
to guidelines and be appropriately trained, the solution is not to leave all 

















unique qualifications to provide sedation, their availability is variable 
(31)
 and 
is limited by commitments to the operating room 
(32)
.   
Furthermore level 1 health care facilities in South Africa don’t usually employ 
specialists of any kind but are responsible for administration of PSA as 
determined in the L1/L2/L3 Acute Hospital Packages of care Booklet 
(33)
, 
published by the Department of Health.  
Nevertheless PSA administration by non-anaesthetists is often a contentious 
subject, as the following study highlights. 
In a study from Scotland a questionnaire was designed to gauge opinion of 
consultant anaesthetists in Scotland on the practice of conscious sedation by 
dentists. Of the 366 questionnaires sent, 235 were returned and valid. In 
general, those questioned felt that the provision of sedation in a hospital 
setting was more appropriate than in general dental practice. While a majority 
(65%) thought that it was unrealistic for anaesthetists to provide all sedation 
for dental treatment, 63% of the questioned anaesthetists also disagreed with 
current dental sedation practice with the dentist being the operator and 






Models of PSA administration  
To provide a solution for this dilemma more and more sedation services are 















Table 3: Outcomes of PSA administered by nurses 









































recovery” in nurse 
group; 
Study not 
blinded and not 
randomized; 
poor design; 
however one of 































ns of above 
Success in 97% 
(chloral hydrate 















PSA administered by non-specialists in the ED
PSA administered in an emergency department setting requires a unique set of 
skills. The Casualty patient requiring PSA often suffers from very painful 
conditions and additionally is rarely fasted and frequently intoxicated. This 
predisposes patients to over-sedation and airway problem when compared 
with elective patients receiving sedation for less painful procedures like 
cataract surgery or imaging as discussed above (table 3). Drugs and dosages 
have to be adjusted and titrated to suit individual patients’ needs. Airway and 
monitoring skills have even greater priority than in the setting of elective 















While a number of studies have examined the skills of dedicated Emergency 
Physicians in terms of procedural sedation and analgesia, there is very little 
literature on the safety of procedural sedation administered by family 
physicians. At least in South Africa (and many rural settings around the 
world) the medical officer (MO) or family physician is often responsible for 
provision of care in the emergency department of the District Hospitals and 
Community Health Centres.  
Few studies report outcomes of PSA at the hands of the medical officers and 
family physicians 
(37)
 or the use of procedural sedation for dilatation and
curettage for patients with incomplete abortions. 
There is consequently a gap in knowledge as to the outcomes of PSA
delivered by general medical officers and Family Physicians. This research, 
by evaluating the outcome of PSA administered by Medical Officers (MO) in 
a district hospital in the Western Cape, aims to contribute towards closing this 
gap. 
PSA and fasting 
One of the advantages of PSA over General Anaesthesia (GA) is that it allows 
preservation of patients' airway reflexes. Fasting, which is ideally required
before deep sedation and GA, where airway reflexes are not preserved, is not
always feasible in emergencies. Some studies and guidelines have examined 
and commented on the need for pre-procedure fasting to minimise aspiration 
among patients undergoing procedural sedation and analgesia for emergency
procedures
(38)
. The American College of Emergency Physicians Clinical 
Policies Subcommittee on Procedural Sedation and Analgesia issued a
recommendation based on ‘preliminary, inconclusive or conflicting evidence, 
or on panel consensus’. The recommendation states: “recent food intake is not 
a contraindication for administering procedural sedation and analgesia”
(28)
.
A study conducted by Bell in an emergency department in Australia compared 
patients who last ate or drank more than 6 and 2 h from induction, 

















cases of aspiration in either group. Out of 118 patients who fasted, 1 (0.8%) 
vomited, as did one of 282 patients (0.4%) who did not fast
 (39)
. 
A further systematic review of the literature conducted by Thorpe et al with 
the aim of evaluating the evidence for risk of pulmonary aspiration during 
emergency procedural sedation in adults found only one reported case of 
pulmonary aspiration during emergency procedural sedation, among 4657 
adult cases and 17  672 paediatric cases reviewed(40). 
Routine fasting has not proven to be beneficial prior to procedural sedation in 
the majority of patients at the Emergency Department. 
However, patients undergoing sedation or analgesia for elective procedures 
should be fasted to allow for gastric emptying before the procedure, in 
concurrence with the ASA Guidelines for pre-operative fasting. The 
guidelines recommend fasting period of 2 hours for clear liquids, 4 hours for 
breast-milk and 6 hours for other milk and solid food. 
In this research most of the ED patients that received PSA were not fasted, 
while all of the elective patients, receiving PSA for D&C of retained products 
of conception were fasted for 6 hours as per ASA guidelines.  
 
Commonly used PSA Drugs 
The drugs that were used for PSA on the patients reviewed in this research 
were Ketamine, Nitrous oxide, Midazolam, Morphine, Valoron (=Tilidin 
hydrochloride) and Propofol. These were used either as single agents or in 
combination within the dosages specified in the table below. 
 
 
Table 4: Commonly used PSA drugs (1,41) 







0.01-0.1 mg/kg IV initially; 
may repeat with 25% of initial 
dose after 3-5 min;  
1-2 min 30-60 min Respiratory depression or 
hypotension may occur, esp. 
In combination with opioid; 
does not provide analgesia; 















Morphine sulfate Starting dose 0.1 mg/kg 
iv/im/sc; 
Maintenance 5-20 mg/ 70 kg 
adult; 





2-4 hours May cause chest wall rigidity, 
apnoea, respiratory 
depression, or hypotension 
due to histamine release; 
nausea and vomiting; action 




Adults: 20drops 3-4 times 
daily; 
Paeds: One mg/ kg per single 
dose should not be exceeded 
45 min 3-4hrs Similar side effect profile to 
morphine sulphate 
Ketamine 0.2-0.75 mg/kg IV infused over 
2-3 min in adults;
1-1.5 mg/kg slow IV push (not
to exceed 0.5 mg/kg/min), may
administer additional doses of
0.5 mg/kg IV q10-15min
1-2min 30-60 min increases bronchial and 
salivary secretions; increases 
heart rate, blood pressure, and 
intracranial pressure; 
emergence hallucinations; 
pharmacologic effects NOT 
reversible 
Propofol Adult 
Monitored anaesthesia care 
(MAC) sedation: 0.5 mg/kg IV 
infused over 3-5 min initially 
Maintenance: 25-75 
mcg/kg/min IV or incremental 
IV bolus doses of 10-20 mg 
<1 min 3-10 min Provides rapid onset and 
recovery phase, and brief 
duration of action; 
anticonvulsant properties; can 
rapidly cause deepening 
sedation; 
causes cardiovascular 
depression and hypotension 
Nitrous oxide Inhale 1:1 mixture of oxygen 
and nitrous oxide via handheld 
mask or mouthpiece 
Typically, patients are to 
maintain the seal to ensure 
adequate inhalation; once 
sedation is approached, the
patient will lose seal and allow 
the mask/mouthpiece to fall




Very low side effect profile. 
Good safety record even in 
small children. Can cause 
nausea and vomiting; 
PROLONGED (> 1hour) 
exposure causes bone marrow 
suppression; not usually 
harmful when used for PSA 
Drugs like Alfentanyl and Remifentanyl are not further discussed here as they
were not available to level 1 district hospitals in South Africa at the time of 
study. 
Of all above drugs, Ketamine stands out, because of its lack of a characteristic 
dose-response continuum by progressive titration, which is typical for other 
sedatives. At doses below a certain threshold, ketamine produces analgesia 
and sedation. However, once the critical dosage threshold of roughly 1–1.5 
mg/kg IV is reached, the characteristic dissociative state abruptly appears. 
Because of this, the dissociative state is not consistent with the Joint 

















definitions of moderate sedation, deep sedation, or general anaesthesia; 
therefore, ketamine must be considered from a different perspective than 




It is because of these 
characteristics that Ketamine still is commonly used for PSA. The dissociative 
state it produces at relatively low dosages while at the same time allowing the 
patient to maintain protection of his airway make it a safe and efficient drug 
for PSA in the hand of the “Non-anaesthetist”. 
All of above drugs have been evaluated in a number of trials and found to be 
safe, with an acceptable side effect profile for PSA. 
Morphine, while still used in procedural sedation, is less popular than shorter 
acting opiates like Fentanyl. 
In our setting the use of Morphine was dictated by availability and familiarity 
of all providers with the drug. The long half time of morphine can cause 
respiratory depression that lasts longer than the actual procedure and as such 
warrants close monitoring following PSA and might delay discharge time. 
The table below outlines details of studies that examined safety and efficiency 

















Table 5: Evidentiary Table- PSA drugs (28) 
Study Design Findings Limitations Conclusions 
Chudnofsky 




ED study of 70 patients aged >18 yrs 
who received 0.07 mg/kg of IV 
midazolam followed by 2 mg/kg of 
IV ketamine for 
I&D  (26%), fracture/joint reduction 
(26%), and other (8%); there were no 
episodes of hallucinations, delirium, 
or other 
Emergency reactions; 18 (25%) 
patients recalled (pleasant or un 













effective and safe 
procedural 
analgesia in 
adult ED patients 





ED study of 266 patients aged 4.5 
months to 16 y to evaluate frequency 
and severity of adverse effects in 
patient receiving ketamine with or 
without 
midazolam for sedation; 129 
patients received ketamine and 137 
received ketamine and midazolam; 













Observational study 30 children aged 18 mo to 8 y; 
bolus of 1.5 mg/kg produced adequate 
sedation in 
17/18 (94%) patients 
Design, small 
numbers 
Ketamine is an 
effective 
method of PSA in 
children 




392 patients 1-18yrs received
Propofol 1mg/kg +/- additional 0.5
mg/kg + narcotic.
O2 Sats maintained in 95%; partial 
airway obstruction in 3%, 0.08%





Propofol is safe and 
effective when 
administered in the 
ED 
Gall et al (46) Prospective,
multicentre clinical 
trial 
Examination of  frequency of adverse 
events in 7511 sedation events of 
children sedated with 50% Nitrous 
oxide and oxygen over a broad range 
of non-specialised facilities. A mean 
of 0·33 % (SD 0·10) children had 
major adverse events. 
No major 
limitations 
premixed 50 % 
Nitrous oxide 
and Oxygen is safe for 
procedural sedation in 
children 
Above table shows evidence that suggests that the drugs used in this research 
have all previously shown to be safe. 


















Equipment and Monitoring of patients receiving PSA 
  
Equipment and monitoring in any medical situation is always dictated by the 
“worst possible case scenario”. Although rare, PSA could potentially result in 
respiratory arrest, cardio-pulmonary arrest or anaphylactic shock, following 
an allergic drug reaction. 
The incidence of complications is dependent on type and dose of drugs, the 
procedure that is performed, experience of sedation provider and patient state 
of health. 
As such the appropriate monitors and equipment to manage airways, allergic 
reactions and drug overdoses and treat respiratory and cardio-pulmonary 
arrest should be readily available. This includes oxygen, suction, medications, 
and advanced life support equipment (bag-mask ventilation device and 
intubation equipment) 
The minimum requirements for monitoring of patients undergoing PSA are 
specified in all of above mentioned PSA guidelines 
(27-29)
. Vital signs should 
be obtained and monitored before, during and after procedure. Vital signs 
include respiratory rate, oxygen saturation, exhaled carbon dioxide, heart rate, 
blood pressure and cardiac rhythm monitoring via ECG. The patient’s 
consciousness level should be monitored by testing his ability to follow 
commands. 
Documentation of the patient’s status before, during and after procedure is 
recommended. 
According to a study conducted by Newman et al, the highest risk of serious 
adverse events following administration of PSA is within 25 minutes of the 




This study illustrates two things; monitoring after a procedure, especially a 
short procedure is important because the depressing effect of PSA drugs 
persist after procedure is concluded. Ideally this should be done by a 

















 On the other hand it shows that discharge after PSA within an hour is in 




There is plenty of scope for future research in the field of PSA in general and in 
the field of PSA by non-anaesthetists in particular.  
PSA using inhalational agents other than nitrous oxide is certainly a field for 
future research. 
Research into optimal dosing strategies for ED Propofol
(49)
 as well as “Ketafol” 
(Ketamine and Propofol combination), including variations of dosing based on 
patient- age, underlying illness and weight should continue. Hand in hand with 
introduction of Propofol into ED-PSA goes research into the impact of additional 
monitoring modalities on the incidence of Propofol (and PSA) related respiratory 
events. Of special interest would be the role of capnography in PSA in general 
and in Propofol PSA in particular. 
Predictors of adverse events, including patient factors, like non-fasting status and 
mild intoxication which is commonly encountered in South Africa EDs, PSA 
medications uses and PSA provider factors (anaesthetist vs trained/ untrained 
MO/ Generalist) deserve to be examined closer. 
Overall larger studies will be required to accurately predict the incidence of 
adverse events of PSA in the emergency department. 
An interesting field, especially for family physicians would be research focusing 
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Objectives: This study aimed to research efficacy and safety of procedural 
sedation and analgesia (PSA) administered by medical officers (MOs), without 
formal anaesthetic training, in a South African district hospital.  Design: This is a 
retrospective descriptive study. Setting: The study took place in the Emergency 
Department (ED) of False Bay Hospital (FBH), a level one hospital in the 
Southern suburbs of the Cape Town Metro health district.  Subjects: All patients 
who received procedural sedation and analgesia at FBH between March 1, 2007 
and August 31, 2009 were included.  Outcome measures: Variables that were 
recorded in the logbook/ data extraction sheet included age, sex, physical status as 
determined by the American Society for anaesthetists (ASA status), procedure, 
fasting and intoxication status, PSA medications, adverse effects, rescue 
manoeuvres performed, if any, and time to discharge. Data was entered into an 
Excel spreadsheet and analysed. Analysis was largely descriptive and clinical and 
demographic data have been presented as means (SDs), medians, ranges, and 
proportions as appropriate. Success of sedation and incidence of adverse effects 
have been presented as proportions. Results: Of 166 patients, 140 (84.33%) 
showed a good level of sedation. Fourteen patients (8.43%) were inadequately 
sedated. Five patients were too deeply sedated (3%) but showed no signs of 
respiratory compromise and seven patients (4.2%) developed respiratory side 
effects. All respiratory complications were treated with simple airway 
manoeuvres. No patients required intubation or experienced respiratory problems 
after waking up. There was no significant difference in the risk of adverse effects 
between the fasted and non-fasted patient groups. Patient who were mildly 
intoxicated and received PSA were at a higher risk of adverse effects. Due to 
small numbers of subjects these findings were not statistically significant. 
Conclusion: Procedural sedation and analgesia can be administered safely by 
Medical Officers. Future research should expand on PSA research in this setting 

















Procedural sedation and analgesia is a skill commonly required when dealing 
with patients in the emergency department (ED). Typical procedures which can 
be performed under PSA in the ED or minor theatre setting are reduction of 
fractures and dislocations (commonly shoulder, hip, elbow, jaw) , incision and 
drainage of abscess (I&Ds) , laceration repair in children, foreign body (FB) 
removal or evacuation of retained products of conception (RPOC).  
Omitting to provide sufficient analgesia is associated with a number of unwanted 
physiological and psychological side effects, including increased sympathetic 
outflow, peripheral vascular resistance, myocardial oxygen consumption, 
production of carbon dioxide (CO2), hypercoagulability, decreased gastric 
motility, decreased immune function, and the subsequent development of chronic 
pain.
 (1-3) 
In the last decade a lot of research has been conducted, proving safety and
efficacy of PSA when administered by emergency physicians in ED Units around
the world.
There is a paucity of studies on PSA administration by non-specialists in the
public health sector in South Africa.
(4)
The majority of the population (over 80%)
is serviced by the state funded public sector hospitals which are often 
overcrowded and under-resourced.
(5)
According to the South African Department of Health 
(6)
, it is the responsibility of
the MO or family physician to care for patients in the emergency room and 
administer of PSA.
(7)
The objectives of this study are to analyze safety and efficacy of PSA when 
provided by MOs in a South African peri-urban district hospital. Furthermore the 
influence of fasting- status and intoxication on sedation outcome and adverse 
effect rate will be examined. 
Setting 
False Bay Hospital is situated in Fish Hoek in the southern suburbs of the 















 The hospital is attended by a diverse group of patients, including patients 
from a very low socio-economic background, as well as a number of wealthier 
patients, belonging to medical aids. 
It is a District Hospital with capacity of 75 inpatient beds. It has two operating 
theatres, an outpatient department (OPD) and a Casualty department with an 
annual headcount of about 14000 patients.  
At the time the study was conducted, the Casualty department was staffed by 
medical officers, with post-graduation working experience between 5 and 12 
years and no formal emergency medicine or anaesthetic training.  
Due to lack of trained staff the hospital had no PSA service prior to 
commencement of the study. This is a situation that is mirrored in many of the 
smaller primary healthcare facilities in South Africa. Procedures in the ED
were either conducted without PSA or referred to a secondary hospital.
Prior to 2007 dilatation and curettage (D&C) of uterus following incomplete
or missed abortion were only undertaken on selected days when a local
General Practitioner (GP) with a diploma in anaesthetics (DA) was available.
On days when the GP was unavailable, patients who required a D&C were
referred to a secondary hospital. The author attended an accredited two year
diploma course in conscious sedation at the University of the Western Cape
(UWC) and subsequently provided in-house training of interested medical and 
nursing staff.
PSA Guideli es 
(8-10)
were circulated to staff involved in PSA and adhered to. 
Methods 
Records of all patients that presented to the ED of False Bay Hospital, 
between March 1 2007 and August 30, 2009, requiring PSA were 
retrospectively evaluated, as a retrospective consecutive case series. 
Patients who received medications for the purpose of procedural sedation and 

















patients who had incomplete abortions and were treated in the minor operation 
theatre (OT) of the same hospital with a D&C under PSA were included. 
Patients who received any of the drugs usually administered for PSA for 
endotracheal intubation, seizure control, and analgesia without associated 
procedure were not included in the study. 
The treating medical officer in the Casualty department was responsible for 
selection of patients that were deemed suitable for PSA at a level 1 facility, as 
well as choice of agents used for PSA. All healthcare staff participating in PSA 
had in-house training in the use of relevant PSA medication and standardized 
guidelines 
(8-10)
 were followed. 
Drugs were used at doses suitable for PSA as opposed to anaesthetic doses. 
Propofol was mixed into a 1:1 solution with Ketamine and commenced at a 
dosage of 0.2mg/kg for each drug and then slowly titrated to desired effect in 
2mls increment (1ml of the mixed solution contained 5mg of Propofol and 
Ketamine each). 
Ketamine was used at a starting dose of 0.5mg/ kg and slowly titrated in 
increments of 0.2 mg/kg. 
  Drug choices were up to the attending MO. The author attended a “Conscious 
sedation diploma” course as offered by UWC and provided some of the in-house 
training. 
All MOs administering PSA had attended ACLS, ATLS and PALS courses. 
Patients selected for PSA at False Bay Hospital were generally “healthy”, 
meaning ASA (American Society of Anaesthetists classification) 1 or 2, or stable 
ASA 3 patients, free of psychiatric disease.  
Fasting status and intoxication with alcohol was evaluated and decision to 
proceed or defer procedure was made on a case to case basis by the responsible 
MO. None of the patients in the Casualty group were fasted. Ten patients were 
mildly intoxicated but found suitable for PSA. One patient’s procedure was 
deferred due to the level of intoxication. 
All of the patients for D&C were fasted. 















Ethics approval for this study was obtained from the UCT Ethics committee. 
Each procedural sedation event was recorded on a standardized Anaesthetic 
record sheet (appendix 1).   
Variables that were recorded included age, sex, ASA status, presenting problem, 
fasting status, clinical impression of intoxication, PSA medications and dosages 
used, adverse effects, rescue manoeuvres performed, if any, time to discharge if 
discharged or other disposal of patient. 
Patients were monitored throughout the procedure with continuous pulse 
oximetry and heart rate measurements, as well blood pressure measurements 
before commencement of procedure and at two minute intervals.  
Readiness for discharge was determined in accordance with an Aldrete score of
9/10.
Adverse events were categorized as follows: 1) apnoea- no respiratory effort 
for >20sec; 2) desaturation-O2 saturation < 93%; 3) airway manoeuvre
required (bag/valve ventilation=BVM) 4) bradycardia- HR<50 beats; 5)
inadequate sedation+/- cancellation of procedure due to failure of PSA; 6)
vomiting/ nausea; 7) hallucinations.
Results 
The data was entered into an Excel spreadsheet and analysed. Data analysis is
largely descriptive and clinical and demographic data has been presented as
means (SDs), medians, ranges, and proportions as appropriates. Success of
sedation and incidence of adverse effects have been presented as proportions.
 The mean age was 23 years (SD 17.98). The oldest patient was 88 years and the 
youngest patient was 3 months old. Table 1 describes the frequency of other 
demographic variables. 
The intended procedures could be completed in 165 of 166 patients (99.4%). Nine 
patients (5.42%) experienced adverse effects, all of which were minor, with no 















records and review of Mortality and Morbidity (M&M) meetings for the time 
span concerned.  
Table 2 contains the breakdown of adverse events for PSA study patients 
There was no statistically significant difference between complication rate for 
male and female patients. (p > 0.05) 
There was a statistical difference in the age of the patients that experienced 
complications versus the age of the patients that did not (p=0.0024). The patients 
that experienced side effects from their treatment were on average older with a 
median age of 40 years versus a median age of 22 years for the patients that did 
not experience side effects. 
The youngest patient experiencing adverse effect was 19 years.
When analyzing the different medication groups for complications, the numbers
were too low for statistical analysis. However, there was a trend for a higher
complication rate with addition of Propofol and with use of multiple sedation
drugs. 
When analyzing adverse events in fasted, versus non-fasted, versus intoxicated 
patients, the numbers were too small to arrive at statistically significant
conclusions, but there was a tendency for intoxicated patients to develop
complications, while there was little difference in adverse effect rate (AER)
between fasted and non fasted patients (Table 3)
One hundred and forty three patients were discharged following their procedure.
The remaining 23 patients required admission or referral for definite treatment.
None of the admissions or referrals was related to PSA. The mean discharge time
was 73 minutes (SD 60.33%) with shortest discharge time of 10 minutes and





















Table 1: Demographic details of PSA patients 
Variable No (%) of patients 
Gender  
Male 70 (42.2) 
Female 96 (57.8) 
Age  
Paediatric patient (<18 yrs) 57 (34) 
ASA  
ASA1 142 (85.6) 
ASA2 11 (6.6) 
ASA3 13 (7.8) 
Procedure  
Incision and Drainage 56(33.5) 
Orthopaedic 31(18.5) 
Evacuation of RPOC 28(17.7) 
Laceration repair 24(14.4) 
Lumbar Puncture 8(4.6) 
Other 19(11.3) 
Fasting status  
Not fasted, not intoxicated 129(77.7) 
Not fasted & intoxicated 8 (4.8) 





































Midazolam +/- N2O 1 0 0 0 5/6 (83.3) 0(0) 
Opiate+Midazolam+Ketamine +/- 
N2O 2 2 1 0 29/34 (85.3) 4(2.4) 
Ketamine+Midazolam +/- 
N2O 0 1 0 1 61/63 (96.8) 4(2.4) 
Single agent  Midazolam or 
Ketamine 1 0 0 0 49/50 (98) 2(1.2) 
Opiate+Midazolam +/- N2O 0 0 0 0 13/13 (100) 4(2.4) 
Total (Percent) 4(2.41) 3(1.81) 1(0.6) 1(0.6) 
157/166 
(94.6) 14(8.4) 
Chi 2 test: p=0.24; not statistically 
significant 
PONV= Post operative nausea and 
vomiting 
Table 3: Adverse events in relation to fasting status and intoxication





Not fasted, not intoxicated 123(95.3) 6(4.7) 129 
Not fasted and intoxicated 7(87.5) 1(12.5) 8 
Fasted 27(93.1) 2(6.9) 29 


















The South African Department of Health guidelines
 
place the provision of PSA 
under the responsibility of level 1 hospitals. 
(7) 
This research was conducted in such a hospital, staffed by medical officers, to 
determine the outcome of procedural sedation and analgesia (PSA).  
The adverse effect rate (Complication rate) overall was low and in keeping with 
the literature from other countries.
(11-14)
 
An unexpected research outcome was detection of a significant difference in side 
effects in relation to age. The median age of all patients who experienced 
complications was 40 years versus 23 years in the group of patients that 
experienced no complications (Two-sample Wilcoxon rank-sum test: P = 0.0024). 
This might have two reasons. For one, a higher age is known to be a risk factor 
for anaesthetic complications and complications of PSA 
(15)
. 
Most of the paediatric patients received lower doses and fewer PSA drugs. More 
than one third of all children (n=22;38.6%) presented for laceration repair while 
the more painful I&D of abscess was the most common procedure in adults with 
over 40% of patients attending for this reason (n=45;41.28%). Laceration repair 
requires a “lighter” anxiolytic regimen of medication in order for the child to 
allow infiltration of the affected skin which then fulfils analgesic purpose.  
In addition one might find that the attending MO was in general more “careful” 
when sedating children, and more hesitant to prescribe larger doses or 
combinations of drugs. In how far this might have led to an under-dosing of the 
children involved was not examined here and might be a topic for future research. 
This trend is reflected in the PSA medication that children and adults received. 
While the majority of adults (55 out of 109, 50.5%) received Ketamine and 
Midazolam, most children (42 of 57, 75.4%) had single agents (N2O; Midazolam, 
Ketamine or an opiate) for PSA. 
A trend was found towards a higher risk of complications with multi drug 
regimens and addition of Propofol. This is expected as Propofol is well known for 
its respiratory depressant effect
 (16)
 and a combination of Benzodiazepines and 

















  Future use of this medication combination for PSA will be reviewed. Intoxicated 
patients were also at an increased risk of adverse effects 
Ingestion of alcohol more than doubled complication rate compared to patients 
who were not intoxicated in this case review series.  
While the above findings were not statistically significant, due to small patient 
numbers, they indicated that guidelines, especially with regards to administration
of PSA to intoxicated patients, were not closely followed at all times. While it
could be argued that reductions of a dislocated joint would be more difficult after
some time has passed and as such should be done as soon as possible (5 of 8 
intoxicated patients had dislocated joints), this is definitely not true for incision 
and drainage of an abscess. (2 of 8 intoxicated patients received PSA for drainage
of abscess) These kinds of procedures should be done electively with a fasted and
sober patient. One of the eight intoxicated patients suffered side effects by way of
a short spell of apnoea. This patient had received a combination of Ketamine and
Midazolam for PSA as well as morphine for pain relief by ambulance staff en
route to the hospital for a painful dislocated shoulder. 
In this case the combination of alcohol, Morphine and Midazolam (with the 
added Ketamine) predisposed the patient to adverse effects.
There was little difference in complication rate between fasted and not fasted
patients. In fact the complication rate in fasted patients was slightly higher at
6.9% than in not-fasted patients who experienced complications in 4.7%. These
findings were not statistically significant, due to low overall numbers of
complications and low patient rates in both groups.
While for a long time fasting rules have been propagated for PSA as an extension 
of anaesthesia practice, in recent years applicability of nil per os (NPO) 
guidelines for PSA have been called into question
  (18,19).
Limitations 
While this study was a moderately powered retrospective case review, it lacks the 

















induced death or permanent neurological injury are small-in the order of 1 in tens 
of thousands. As such much larger patient numbers (in the order of 50000 
subjects) would be needed to investigate those events. 
Another problem, especially from a patient-centred family physician approach, is 
the rating of a “successful” procedure. The literature shows us that the rate of 
sedative failure has been reported inconsistently by different reporters to be as 
low as 1%-3% 
(20,21)
 or as high as 10%-20% 
(22,23).
 
While success rate depends on the setting (including the drugs used, the provider 
and psychological support as well as presence or absence of a parent in PSA of 
children) it also depends on the definition used for successful sedation. 
In this study PSA was judged to be successful if the procedure could be 
completed. The condition of the patient was not further described. As such this 
study would have described a child that received PSA but screamed during the 
procedure and then slept deeply afterwards as a procedural “success” when in 
reality it was not.  
A patient satisfaction questionnaire is probably the only way to ascertain true 
“success” of a procedure in a holistic, patient-centred way and more research on 
PSA should be planned in that way. 
Some might feel that lack of a standardized drug regimen was a limitation. 
However, the research question was not to prove superiority of a certain drug for 
provision of PSA but to describe that PSA in general can be safely administered 
by non-specialised but trained medical staff. 
 
Conclusion:  
Procedural sedation and analgesia can be administered safely by Medical Officers 
in District Hospitals. Future research should expand on PSA research in this 
setting and focus not just on safety but also on patient satisfaction with PSA. 
Newly qualified doctors on South Africa are likely to spend the first few years of 















should be taught to a wider number of doctors (as a post-graduate course) and 
even medical students in their undergraduate curriculum. 
Adherence to PSA guidelines, knowledge of drugs and basic airway management 
is of upmost importance. 
Most importantly, the relief and avoidance of pain is central to our role as 
humane professionals and to provision of quality health care. 
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Age distribution of study participants is further analyzed in figure D1 




Fig D2: Number of children and adults 
 
 
Fifty-seven patients or roughly one third of patients were under 18 years of age 
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PSA medication used is outlined below. 
There was a significant difference in medication use between children and adults. 
Children were mainly treated with single agents, while adults were more prone to 
receive drug combinations, most commonly Ketamine and Midazolam. 
Close to 70% of patients were treated with Ketamine and Midazolam either as 
single agents or combined with addition of N2O. 
Tab 5: PSA medication used (distinguishing between adults and children) 





Ketamine+Midazolam +/- N2O 55 8 63 37.95 
Single agent ( Midazolam+/- N2O or 
N2O or Ketamine or Opiate)  
7 43 50 30.12 
Opiate+Midazolam+Ketamine +/- N2O 32 2 34 20.48 
Opiate+Midazolam +/- N2O 9 4 13 7.83 
Ketafol (=Ketamine+Propofol) + 
Midazolam +/- N2O 
6 0 6 3.61 
Total 109 57 166 100 
Discharge time 
One-hundred forty three patients (86.14%) were discharged following their 
procedure. The remaining 23 patients were admitted or transferred. The 
admissions and Transfers were not related to a sedation problem.  Discharge time 
for all PSA patients varied between 10-222 minutes with a mean of 73 (SD = 
60.33) minutes. 
Sixty percent of patients were discharged within one hour of the procedure and 






























0-20 13 9.10 13 9.10 
21-40 55 38.46 68 47.55 
41-60 23 16.08 91 63.64 
61-80 7 4.90 98 68.53 
81-100 5 3.50 103 72.03 
101-120 4 2.80 107 74.83 
121-140 5 3.50 112 78.32 
141-160 12 8.40 124 86.71 
161-180 5 3.50 129 90.21 
181-200 11 7.69 140 97.90 
201-220 2 1.40 142 99.30 
>220 1 0.70 143 100 
Admission 15    
Transfer 8    
 









Discharge time (min) 
Discharge time (in cum. percent) 
 
Sample size 143patients 
 Lowest D/C time in 
minutes 
10 min 
Highest D/C time in 
minutes 
222 min 


















Level of sedation 
Eighty four percent of patients were sedated to the correct level of sedation for 
the procedure. Eight percent of patients were insufficiently sedated and 
experienced pain during the procedure. This might have to do with a numbers of 
factors like inappropriate drug choices or dosing for the procedure planned or 
previous drug use of the patient which makes patients susceptible to PSA failure. 
Seven percent of patients were too deeply sedated. Three percent experienced 
mild respiratory side effects. 
 









Fig D4: Level of sedation achieved 
 




Level of Sedation 






Level of sedation Number Percent 
Correct level of sedation 
  
140 84.33% 
Insufficient sedation 14 8.43% 
Deep sedation only 5 3.02% 





















Adverse effects in relation to gender 
 
There was no statistically significant difference between complication rate for 
male and female patients. (p>0.05) 
 
Tab D3: Adverse effects in relation to gender 
 
Adverse effects in relation to gender 
























 Adverse effects in relation to age 
 









Two-sample Wilcoxon rank-sum test: P = 0.0024 
 
There was a statistical difference in the age of the patients that experienced 
complications versus the age of the patients that did not (p=0.0024). The patients 
that experienced side effects from their treatment were on average older with a 
Complication rate in relation to age in years 
Complication Number Median age Min Max 
No complications 157 22 0.25 88 
Complications 9 40 19 81 
Total 166 23 0.25 88 

















median age of 40 years versus a median age of 22 years for the patients that did 
not experience side effects. 
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Initials ASA Medication 
used 
Fasted 
Y/N; 
ETOH? 
Procedure/ 
Pathologies 
Outcome/ 
Analgesia 
achieved 
Complications/ 
Rescue Manoeuvres 
used 
Discharge time 
(min) 
